vs
ENVIRI Corp（NVRI）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Royalty Pharma plc的季度营收约是ENVIRI Corp的1.1倍（$622.0M vs $555.0M），Royalty Pharma plc净利率更高（34.4% vs -15.2%，领先49.6%），Royalty Pharma plc同比增速更快（4.8% vs -0.8%），过去两年Royalty Pharma plc的营收复合增速更高（4.6% vs -3.8%）
Enviri集团是总部位于美国宾夕法尼亚州费城的环保企业，业务覆盖全球30多个国家，员工总数约1.2万人。公司专注为钢铁、铁路、能源等大型工业领域客户解决复杂的环保相关问题，提供针对性的环境治理解决方案。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
NVRI vs RPRX — 直观对比
营收规模更大
RPRX
是对方的1.1倍
$555.0M
营收增速更快
RPRX
高出5.5%
-0.8%
净利率更高
RPRX
高出49.6%
-15.2%
两年增速更快
RPRX
近两年复合增速
-3.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $555.0M | $622.0M |
| 净利润 | $-84.3M | $214.2M |
| 毛利率 | — | — |
| 营业利润率 | -6.4% | 62.4% |
| 净利率 | -15.2% | 34.4% |
| 营收同比 | -0.8% | 4.8% |
| 净利润同比 | 0.7% | 2.9% |
| 每股收益（稀释后） | $-1.04 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NVRIRPRX
| Q4 25 | $555.0M | $622.0M | ||
| Q3 25 | $574.8M | $609.3M | ||
| Q2 25 | $562.3M | $578.7M | ||
| Q1 25 | $548.3M | $568.2M | ||
| Q4 24 | $559.2M | $593.6M | ||
| Q3 24 | $573.6M | $564.7M | ||
| Q2 24 | $610.0M | $537.3M | ||
| Q1 24 | $600.3M | $568.0M |
净利润NVRIRPRX
| Q4 25 | $-84.3M | $214.2M | ||
| Q3 25 | $-22.3M | $288.2M | ||
| Q2 25 | $-47.6M | $30.2M | ||
| Q1 25 | $-13.4M | $238.3M | ||
| Q4 24 | $-84.9M | $208.2M | ||
| Q3 24 | $-13.2M | $544.0M | ||
| Q2 24 | $-13.6M | $102.0M | ||
| Q1 24 | $-18.0M | $4.8M |
营业利润率NVRIRPRX
| Q4 25 | -6.4% | 62.4% | ||
| Q3 25 | 2.9% | 70.1% | ||
| Q2 25 | -1.3% | 36.3% | ||
| Q1 25 | 5.6% | 94.0% | ||
| Q4 24 | -11.4% | 60.9% | ||
| Q3 24 | 6.5% | — | ||
| Q2 24 | 5.1% | 50.2% | ||
| Q1 24 | 4.3% | -13.0% |
净利率NVRIRPRX
| Q4 25 | -15.2% | 34.4% | ||
| Q3 25 | -3.9% | 47.3% | ||
| Q2 25 | -8.5% | 5.2% | ||
| Q1 25 | -2.4% | 41.9% | ||
| Q4 24 | -15.2% | 35.1% | ||
| Q3 24 | -2.3% | 96.3% | ||
| Q2 24 | -2.2% | 19.0% | ||
| Q1 24 | -3.0% | 0.8% |
每股收益（稀释后）NVRIRPRX
| Q4 25 | $-1.04 | $0.49 | ||
| Q3 25 | $-0.28 | $0.67 | ||
| Q2 25 | $-0.59 | $0.07 | ||
| Q1 25 | $-0.17 | $0.55 | ||
| Q4 24 | $-1.07 | $0.46 | ||
| Q3 24 | $-0.16 | $1.21 | ||
| Q2 24 | $-0.17 | $0.23 | ||
| Q1 24 | $-0.22 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $103.7M | $618.7M |
| 总债务越低越好 | $1.6B | $9.0B |
| 股东权益账面价值 | $255.1M | $9.7B |
| 总资产 | $2.7B | $19.6B |
| 负债/权益比越低杠杆越低 | 6.10× | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资NVRIRPRX
| Q4 25 | $103.7M | $618.7M | ||
| Q3 25 | $115.4M | $938.9M | ||
| Q2 25 | $97.8M | $631.9M | ||
| Q1 25 | $102.5M | $1.1B | ||
| Q4 24 | $88.4M | $929.0M | ||
| Q3 24 | $110.2M | $950.1M | ||
| Q2 24 | $104.0M | $1.8B | ||
| Q1 24 | $103.9M | $843.0M |
总债务NVRIRPRX
| Q4 25 | $1.6B | $9.0B | ||
| Q3 25 | — | $8.9B | ||
| Q2 25 | — | $8.0B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | $1.4B | $7.6B | ||
| Q3 24 | — | $7.6B | ||
| Q2 24 | — | $7.6B | ||
| Q1 24 | — | $6.1B |
股东权益NVRIRPRX
| Q4 25 | $255.1M | $9.7B | ||
| Q3 25 | $361.1M | $9.6B | ||
| Q2 25 | $376.3M | $9.5B | ||
| Q1 25 | $409.0M | $9.8B | ||
| Q4 24 | $391.5M | $10.3B | ||
| Q3 24 | $484.0M | $10.3B | ||
| Q2 24 | $485.7M | $9.8B | ||
| Q1 24 | $500.9M | $9.9B |
总资产NVRIRPRX
| Q4 25 | $2.7B | $19.6B | ||
| Q3 25 | $2.8B | $19.3B | ||
| Q2 25 | $2.8B | $18.3B | ||
| Q1 25 | $2.7B | $17.6B | ||
| Q4 24 | $2.6B | $18.2B | ||
| Q3 24 | $2.8B | $18.0B | ||
| Q2 24 | $2.8B | $17.7B | ||
| Q1 24 | $2.8B | $16.1B |
负债/权益比NVRIRPRX
| Q4 25 | 6.10× | 0.92× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | — | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | 3.66× | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× | ||
| Q1 24 | — | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $38.4M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $-10.5M | — |
| 自由现金流率自由现金流/营收 | -1.9% | — |
| 资本支出强度资本支出/营收 | 8.8% | — |
| 现金转化率经营现金流/净利润 | — | 3.86× |
| 过去12个月自由现金流最近4个季度 | $-39.9M | — |
8季度趋势，按日历期对齐
经营现金流NVRIRPRX
| Q4 25 | $38.4M | $827.1M | ||
| Q3 25 | $34.4M | $702.6M | ||
| Q2 25 | $22.0M | $364.0M | ||
| Q1 25 | $6.6M | $596.1M | ||
| Q4 24 | $36.3M | $742.5M | ||
| Q3 24 | $1.4M | $703.6M | ||
| Q2 24 | $39.0M | $658.2M | ||
| Q1 24 | $1.3M | $664.6M |
自由现金流NVRIRPRX
| Q4 25 | $-10.5M | — | ||
| Q3 25 | $2.7M | — | ||
| Q2 25 | $-17.1M | — | ||
| Q1 25 | $-15.0M | — | ||
| Q4 24 | $1.8M | — | ||
| Q3 24 | $-40.2M | — | ||
| Q2 24 | $5.4M | — | ||
| Q1 24 | $-25.5M | — |
自由现金流率NVRIRPRX
| Q4 25 | -1.9% | — | ||
| Q3 25 | 0.5% | — | ||
| Q2 25 | -3.0% | — | ||
| Q1 25 | -2.7% | — | ||
| Q4 24 | 0.3% | — | ||
| Q3 24 | -7.0% | — | ||
| Q2 24 | 0.9% | — | ||
| Q1 24 | -4.3% | — |
资本支出强度NVRIRPRX
| Q4 25 | 8.8% | — | ||
| Q3 25 | 5.5% | — | ||
| Q2 25 | 6.9% | — | ||
| Q1 25 | 3.9% | — | ||
| Q4 24 | 6.2% | — | ||
| Q3 24 | 7.2% | — | ||
| Q2 24 | 5.5% | — | ||
| Q1 24 | 4.5% | — |
现金转化率NVRIRPRX
| Q4 25 | — | 3.86× | ||
| Q3 25 | — | 2.44× | ||
| Q2 25 | — | 12.06× | ||
| Q1 25 | — | 2.50× | ||
| Q4 24 | — | 3.57× | ||
| Q3 24 | — | 1.29× | ||
| Q2 24 | — | 6.45× | ||
| Q1 24 | — | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NVRI
| Products And Services Service Revenue | $500.2M | 90% |
| After Market Parts And Services Safety And Diagnostic Technology | $23.0M | 4% |
| Railway Track Maintenance Equipment | $16.6M | 3% |
| Railway Contracting Services | $15.9M | 3% |
| Aluminum Dross And Scrap Processing Systems | $3.1M | 1% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
